Square Pharmaceuticals Limited, a publicly traded company, reported 16% up in profit in third quarter (January-March) of the current FY2020 compared to same period of the previous year.
The company’s net profit stood at Tk361.54 crore, against Tk311.79 crore in the same quarter of the previous year, as per an official disclosure posted by the company on Dhaka Stock Exchange (DSE) website on Tuesday.
According to un-audited financial statement, the consolidated earnings per share (EPS) of Square Pharma was Tk 4.28 for the period, against Tk3.69 for the same period last year.
The novel coronavirus outbreak helped augment its drug sales, resulting in the higher profitability, said an official of the pharma company.
Square Pharmaceuticals, one of the leading pharma companies, manufactures and markets various generic pharmaceuticals products, basic chemicals, and animal health products. The company holds 17.73% of pharmaceutical market share. ♦
